EnBio Holdings Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	11,579	10,668	9,575	8,120	8,987	6,840
Revenue Growth (YoY)	7.41%	11.42%	17.92%	-9.65%	31.39%	-7.67%
Cost of Revenue	8,436	8,014	7,092	5,355	6,562	4,950
Gross Profit	3,144	2,654	2,483	2,765	2,425	1,890
Selling, General & Admin	2,028	1,814	1,668	1,407	1,196	1,165
Other Operating Expenses	-	-	-	-	-	107
Operating Expenses	2,020	1,806	1,667	1,407	1,181	1,272
Operating Income	1,124	848	816	1,358	1,244	618
Interest Expense	-170.31	-141	-114	-124	-123	-125
Interest & Investment Income	56.26	60	45	36	25	10
Currency Exchange Gain (Loss)	-45.43	-27	186	65	80	17
Other Non Operating Income (Expenses)	-965.35	-39	133	8	-30	73
EBT Excluding Unusual Items	-1.08	701	1,066	1,343	1,196	593
Gain (Loss) on Sale of Assets	-	-	-	-	-2	11
Asset Writedown	-	-9	-12	-110	-95	-116
Other Unusual Items	-	9	10	-	-1	-
Pretax Income	248.12	701	1,064	1,233	1,098	488
Income Tax Expense	455.9	281	326	437	392	157
Earnings From Continuing Operations	-207.78	420	738	796	706	331
Minority Interest in Earnings	30.47	32	-30	16	-52	-27
Net Income	-177.31	452	708	812	654	304
Net Income to Common	-177.31	452	708	812	654	304
Net Income Growth	-	-36.16%	-12.81%	24.16%	115.13%	-45.23%
Shares Outstanding (Basic)	8	8	8	7	7	7
Shares Outstanding (Diluted)	8	8	8	7	7	7
Shares Change (YoY)	0.20%	1.52%	20.11%	-0.01%	-0.03%	0.07%
EPS (Basic)	-21.90	55.81	88.75	122.26	98.52	46.21
EPS (Diluted)	-21.90	55.81	88.75	122.26	98.47	45.76
EPS Growth	-	-37.11%	-27.41%	24.16%	115.19%	-45.29%
Free Cash Flow	-	-1,441	584	827	1,249	-1,432
Free Cash Flow Per Share	-	-177.93	73.21	124.52	188.04	-215.52
Dividend Per Share	9.000	9.000	8.000	8.000	8.000	-
Dividend Growth	12.50%	12.50%	-	-	-	-
Gross Margin	27.15%	24.88%	25.93%	34.05%	26.98%	27.63%
Operating Margin	9.71%	7.95%	8.52%	16.72%	13.84%	9.04%
Profit Margin	-1.53%	4.24%	7.39%	10.00%	7.28%	4.44%
Free Cash Flow Margin	-	-13.51%	6.10%	10.18%	13.90%	-20.94%
EBITDA	-	1,345	1,254	1,758	1,585	985
EBITDA Margin	-	12.61%	13.10%	21.65%	17.64%	14.40%
D&A For EBITDA	541.25	497	438	400	341	367
EBIT	1,124	848	816	1,358	1,244	618
EBIT Margin	9.71%	7.95%	8.52%	16.72%	13.84%	9.04%
Effective Tax Rate	183.74%	40.09%	30.64%	35.44%	35.70%	32.17%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.